DOI:
10.1055/s-00050348
Indian Journal of Medical and Paediatric Oncology
LinksClose Window
References
Soria JC, Tan DSW, Chiari R. et al
First-line ceritinib versus platinum-based chemotherapy in advanced ALK-rearranged non-small-cell lung cancer (ASCEND-4): a randomised, open-label, phase 3 study.
Lancet 2017;
389 (10072) 917-929
We do not assume any responsibility for the contents of the web pages of other providers.